Skip to main content
Hit enter to search or ESC to close
Controlled Open Randomized Clinical Trial to assess efficacy and safety of an anti-TB drug combination based on high dose Rifampicin, high dose Moxifloxacin and Linezolid for DS smear positive pulmonary TB during the first 8weeks of treatmen (Referencia: PI20/01378)
© 2024 VHIR Annual Report 2022.
Data protection policy
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2022